Telemedicine in Asthma Management: What Clinicians Need to Know

/ Print /
| ShareMore
/ Text Size +
12/9/20 7:00 pm EST
Virtual Webinar
United States


This webinar is jointly provided by Potomac Center for Medical Education and Rockpointe

cancernet Logo 2017                      amedcologo    

In collaboration with the American Lung Association

cancernet Logo 2017    

This activity is supported in part by an independent education grant from AstraZeneca, Sanofi Genzyme and Regeneron Pharmaceuticals.


  • Welcome and Introduction
  • Telemedicine in the Allergy/Immunology Practice
  • Guidance for Implementing Telemedicine for Patients with Asthma
  • Asthma Telemedicine: Navigating the Legal and Regulatory Issues
  • Q&A Session


This activity will cover topics on the diagnosis, treatment, and management of patients with non-small cell lung cancer. Upon completion of this activity, participants should be better able to:

Program Description

Telemedicine is becoming an increasingly common component of healthcare, driven by patient demand and vast improvements in technology. While the integration of telemedicine into daily practice in asthma management has been studied and implemented to a limited extent over the last decade, many allergist and immunologists have had the need for telemedicine thrust upon them very suddenly. Thus, they lack familiarity with the benefits of telemedicine and are likely uncertain on how best to manage patient care in this virtual setting. Hence, these clinicians will require education on best practices for incorporating telemedicine in the asthma and allergist clinic, including different strategies for virtual healthcare visits and remote patient monitoring, how to manage treatment in the telemedicine setting, and how to navigate the complex and continuously evolving legal and regulatory landscape pertaining to telehealthcare. This program will provide clinicians with the most up-to-date information on telemedicine in asthma care to promote easier transitions to this new and necessary form of care for their patients.

Date and Time:

This webinar will be held on:

  • Wednesday, December 9, 2020 7:00 – 8:00 pm ET
  • Tuesday, December 15, 2020 1:00 – 2:00 pm ET

Steering Committee

Wanda Phipatanakul, MD, MS
Professor of Pediatrics
Harvard Medical School
Director, Asthma Clinical Research Center
Boston Children's Hospital
Boston, MA

Jay M. Portnoy, MD
Professor of Pediatrics
University of Missouri-Kansas City School of Medicine
Staff Allergist and Medical Director of Telemedicine
Children’s Mercy Hospital
Kansas City, MO

Jodi Shroba, MSN, APRN, CPNP
Certified Pediatric Nurse Practitioner
Food Allergy Program Coordinator, Allergy Division
Children’s Mercy Hospital
Kansas City, MO

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP
Clinical Pharmacy Specialist, Primary Care
Nashville, TN


The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.

This program is designed to address ACPE competencies, including foundational knowledge, essentials for practice and care, and approaches to practice and care.

At the conclusion of this education, participants should be able to:

  • Describe the benefits and challenges of telemedicine in the asthma/allergy clinic
  • Adopt recommended practices for appropriate integration of telemedicine into asthma patient care
  • Assess the legal and regulatory guidelines and requirements for asthma care via telemedicine

Physician Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Physician Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email

ABIM MOC Designation Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

Pharmacist Accreditation Statement

The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacist Credit Designation

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-009-L01-P).

This is an application-based activity.

For information about this continuing pharmacy education (CPE) activity, please email:

Nursing Credit Statement

This activity has been submitted to the Maryland Nurses Association for approval to award contact hours. The Maryland Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosure Information

The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Disclosures will be made known to the participants prior to the start of the activity.

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.